Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Not applicableUnknownNCT03273608What this trial is testingObservation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC PatientsWho this might be right forHepatocellular Carcinoma Taipei Veterans General Hospital, Taiwan 120
Early research (Phase 1)Looking for participantsNCT06764316What this trial is testingA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerWho this might be right forHepatocellular Carcinoma Bayer 148
Large-scale testing (Phase 3)Study completedNCT01015833What this trial is testingSorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver CancerWho this might be right forAdvanced Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7+7 more National Cancer Institute (NCI) 356
Testing effectiveness (Phase 2)Looking for participantsNCT05751343What this trial is testingAtezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical TrialWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 55
Testing effectiveness (Phase 2)UnknownNCT05582109What this trial is testingEnvafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular CarcinomaWho this might be right forObjective Response Rate (ORR) Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07500220What this trial is testingDual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCCWho this might be right forAdvanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer Beijing Biotech 30
Early research (Phase 1)Study completedNCT01308723What this trial is testingA Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Study completedNCT00321594What this trial is testingBelinostat in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03680508What this trial is testingTSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver CancerWho this might be right forAdult Primary Liver CancerAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer University of Hawaii 42
Testing effectiveness (Phase 2)Study completedNCT00057980What this trial is testingEpirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaWho this might be right forLiver Cancer Northwestern University 8
Testing effectiveness (Phase 2)Study completedNCT00033462What this trial is testingErlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerWho this might be right forAdult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+8 more National Cancer Institute (NCI) 78
Early research (Phase 1)Study completedNCT00047346What this trial is testingErlotinib in Treating Patients With Unresectable Liver Cancer and Liver DysfunctionWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)WithdrawnNCT01859182What this trial is testingSelumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07793695What this trial is testingOral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00956930What this trial is testingChemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or SurgeryWho this might be right forLiver Cancer Northwestern University 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287What this trial is testingTesting A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract CancerWho this might be right forMetastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00335829What this trial is testingBevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryWho this might be right forLiver Cancer Yale University 26
Testing effectiveness (Phase 2)Looking for participantsNCT07227012What this trial is testingSymbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Who this might be right forCarcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more Pfizer 138